Genprex, Inc.
GNPX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595248
No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Genprex, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −5 vs. Q4 2022
- Shares held
- 5.96M
- +1.93M (+47.8%) vs. Q4 2022
- Total value
- $5.42M
- −$412.5K (−7.1%) vs. Q4 2022
- New holders
- 6
- 12 more added
- Sold out
- 11
- 7 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GNPX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $154.9K |
| Q1 2026 | 27 | $169.0K |
| Q4 2025 | 22 | $13.0K |
| Q3 2025 | 21 | $229.5K |
| Q2 2025 | 28 | $152.9K |
| Q1 2025 | 24 | $93.5K |
| Q4 2024 | 22 | $247.0K |
| Q3 2024 | 21 | $79.7K |
| Q2 2024 | 15 | $510.3K |
| Q1 2024 | 17 | $426.0K |
| Q4 2023 | 36 | $1.16M |
| Q3 2023 | 39 | $2.61M |
| Q2 2023 | 38 | $3.64M |
| Q1 2023 | 39 | $5.42M |
| Q4 2022 | 45 | $5.84M |
| Q3 2022 | 43 | $6.29M |
| Q2 2022 | 42 | $6.11M |
| Q1 2022 | 50 | $10.8M |
| Q4 2021 | 47 | $9.78M |
| Q3 2021 | 49 | $15.8M |
| Q2 2021 | 59 | $19.5M |
| Q1 2021 | 72 | $35.4M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Genprex, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 177 | $0 | 0.00% | 00.0% | Unchanged |
| Proequities, Inc. | 32 | $29 | 0.00% | +32 | New |
| Meeder Asset Management Inc | 271 | $247 | 0.00% | −8,903−97.0% | Reduced |
| TCI Wealth Advisors, Inc. | 300 | $273 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 332 | $302 | 0.00% | +5+1.5% | Added |
| National Bank of Canada | 850 | $767 | 0.00% | 00.0% | Unchanged |
| VitalStone Financial, LLC | 400 | $1.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 3,705 | $3.00K | 0.00% | +1,205+48.2% | Added |
| GWM Advisors LLC | 5,000 | $4.55K | 0.00% | 00.0% | Unchanged |
| David Loasby | 10,000 | $8.30K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 9,262 | $8.42K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 9,829 | $9.00K | 0.00% | +1,816+22.7% | Added |
| UBS Group AG | 11,246 | $10.2K | 0.00% | −149,300−93.0% | Reduced |
| Pekin Hardy Strauss, Inc. | 12,578 | $11.4K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 12,600 | $12.0K | 0.00% | −13,000−50.8% | Reduced |
| Citadel Advisors LLC | 13,282 | $12.1K | 0.00% | −22,406−62.8% | Reduced |
| Morgan Stanley | 13,608 | $12.4K | 0.00% | +698+5.4% | Added |
| CCG Wealth Management, LLC | 15,100 | $13.7K | 0.01% | 00.0% | Unchanged |
| Cresset Asset Management, LLC | 17,000 | $15.5K | 0.00% | +17,000 | New |
| Bank of New York Mellon Corp | 17,569 | $16.0K | 0.00% | 00.0% | Unchanged |
| Mariner, LLC | 20,000 | $18.0K | 0.00% | +20,000 | New |
| TCG Advisory Services, LLC | 22,000 | $20.0K | 0.00% | +1,000+4.8% | Added |
| Bank of America Corp | 25,691 | $23.4K | 0.00% | +20,579+402.6% | Added |
| Charles Schwab Investment Management Inc | 29,742 | $27.1K | 0.00% | 00.0% | Unchanged |
| StoneX Group Inc. | 37,476 | $34.1K | 0.00% | +2,326+6.6% | Added |
| Staley Capital Advisers Inc | 50,000 | $45.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 51,307 | $47.0K | 0.00% | −3,593−6.5% | Reduced |
| Verus Capital Partners, LLC | 55,500 | $50.5K | 0.01% | −33,000−37.3% | Reduced |
| Silvercrest Asset Management Group LLC | 56,000 | $51.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 77,219 | $70.3K | 0.01% | +77,219 | New |
| Northern Trust Corp | 81,861 | $74.5K | 0.00% | −4,569−5.3% | Reduced |
| IHT Wealth Management, LLC | 82,372 | $75.0K | 0.00% | +29,997+57.3% | Added |
| Group One Trading, L.P. | 105,067 | $95.6K | 0.00% | +44,713+74.1% | Added |
| Rockefeller Capital Management L.P. | 150,000 | $136.0K | 0.00% | +150,000 | New |
| State Street Corp | 172,439 | $156.9K | 0.00% | +42,700+32.9% | Added |
| Geode Capital Management, LLC | 447,211 | $406.9K | 0.00% | +15,074+3.5% | Added |
| BlackRock Inc. | 568,240 | $517.0K | 0.00% | +3,612+0.6% | Added |
| Vanguard Group Inc | 1,826,600 | $1.66M | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 1,950,000 | $1.77M | 0.04% | +1,950,000 | New |
| Cypress Capital, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −31,569−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −22,644−100.0% | Sold out |
| Per Stirling Capital Management, LLC. | 0 | $0 | 0.00% | −18,162−100.0% | Sold out |
| TCWP LLC | 0 | $0 | 0.00% | −17,500−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −13,200−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −7,991−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Burleson & Company, LLC | – | – | – | – | Not filed |